Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.7950 (1.27%) ($4.7950 - $4.7950) on Fri. Sep. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.7% (three month average) | RSI | 57 | Latest Price | $4.7950(1.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) SPLV(90%) UUP(-33%) USO(-43%) TIP(-5%) TBT(-95%) | Factors Impacting ATRA price | ATRA will decline at least -5.35% in a week (0% probabilities). IBUY(38%) IPO(15%) XRT(45%) IWC(47%) EWY(-32%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.35% (StdDev 10.7%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.52(6.08%) | 10 Day Moving Average | $4.32(11%) | 20 Day Moving Average | $4.52(6.08%) | To recent high | -45.4% | To recent low | 68% | Market Cap | $356m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |